Literature DB >> 11641419

The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering.

S H Lin1, A C Arai, Z Wang, H P Nothacker, O Civelli.   

Abstract

PDZ domain proteins use the PDZ domain binding motif to bind to the C-terminal sequence of membrane proteins to help scaffold them and spatially organize the components of the intracellular signaling machinery. We have identified a sequence at the C terminus of a G protein-coupled receptor, the PrRP receptor, that shares similarities with the C-terminal sequence of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPA-R) subunits that interact with PDZ domain proteins. When coexpressed in human embryonic kidney 293 cells, PrRP receptor was able to coimmunoprecipitate the three PDZ domain proteins known to interact with AMPA receptors: glutamate receptor interacting protein (GRIP), AMPA binding protein (ABP), and protein that interacts with C-kinase (PICK1), but not the PDZ domain protein PSD-95, which does not interact with AMPA receptors. These interactions are sequence-selective as determined by mutagenesis. Furthermore, we show that PrRP receptor forms intracellular clusters when coexpressed with PICK1, and that this clustering effect is dependent on the interaction between the PICK1 PDZ domain and the last four amino acids of PrRP receptor. We found that PrRP receptor interaction with GRIP is not protein kinase C-regulated but may be regulated by other unidentified kinase because okadaic acid dramatically reduced GRIP interaction. By in situ hybridization, we show that the PrRP receptor is expressed in neurons that also express these PDZ domain proteins. We thus demonstrate that PrRP receptor interacts with the same PDZ domain proteins as the AMPA-Rs, raising the possibility that these two proteins could be scaffolded together at the synapse. These results may help to gain important insights into PrRP functions within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641419     DOI: 10.1124/mol.60.5.916

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

Review 1.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics.

Authors:  Yi He; Adam Liwo; Harel Weinstein; Harold A Scheraga
Journal:  J Mol Biol       Date:  2010-11-02       Impact factor: 5.469

3.  Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.

Authors:  Naoe Okamura; Rainer K Reinscheid; Shintaro Ohgake; Masaomi Iyo; Kenji Hashimoto
Journal:  Neuropharmacology       Date:  2009-07-02       Impact factor: 5.250

4.  Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1.

Authors:  Merav Bassan; Hongguang Liu; Kenneth L Madsen; Wencke Armsen; Jiayi Zhou; Tara Desilva; Weizhi Chen; Allison Paradise; Michael A Brasch; Jeff Staudinger; Ulrik Gether; Nina Irwin; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2008-01       Impact factor: 3.386

5.  Evolutionarily conserved bias of amino-acid usage refines the definition of PDZ-binding motif.

Authors:  Takahiko Chimura; Thomas Launey; Masao Ito
Journal:  BMC Genomics       Date:  2011-06-08       Impact factor: 3.969

Review 6.  Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents.

Authors:  Safia Ayachi; Frédéric Simonin
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-02       Impact factor: 5.555

7.  Residue-Level Contact Reveals Modular Domain Interactions of PICK1 Are Driven by Both Electrostatic and Hydrophobic Forces.

Authors:  Amy O Stevens; Yi He
Journal:  Front Mol Biosci       Date:  2021-01-27

Review 8.  Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Authors:  Veronika Pražienková; Andrea Popelová; Jaroslav Kuneš; Lenka Maletínská
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.